Middle East & Africa Opioid Market Size & Outlook
MEA opioid market highlights
- The MEA opioid market generated a revenue of USD 1,166.2 million in 2023.
- The market is expected to grow at a CAGR of 0.5% from 2024 to 2030.
- In terms of segment, ir/ short acting opioids was the largest revenue generating product in 2023.
- IR/ Short Acting Opioids is the most lucrative product segment registering the fastest growth during the forecast period.
MEA data book summary
| Market revenue in 2023 | USD 1,166.2 million |
| Market revenue in 2030 | USD 1,211.0 million |
| Growth rate | 0.5% (CAGR from 2023 to 2030) |
| Largest segment | Ir/ short acting opioids |
| Fastest growing segment | IR/ Short Acting Opioids |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | IR/ Short Acting Opioids |
| Key market players worldwide | Johnson & Johnson, Hikma Pharmaceuticals PLC, Pfizer Inc, AbbVie Inc, Sanofi SA, Sun Pharmaceutical Industries, Grunenthal Pharma |
Other key industry trends
- In terms of revenue, MEA region accounted for 5.1% of the global opioid market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,028.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Opioid Market Scope
Opioid Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Grunenthal Pharma | View profile | 101-250 | Humanes De Madrid, Madrid, Spain, Europe | https://www.grunenthal.es/ |
| Hikma Pharmaceuticals PLC | View profile | 2150 | 1 New Burlington Place, London, United Kingdom, W1S 2HR | https://www.hikma.com |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Middle East & Africa opioid market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to opioid market will help companies and investors design strategic landscapes.
Ir/ short acting opioids was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Middle East & Africa opioid market based on ir/ short acting opioids covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Middle East & Africa opioid market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa opioid market databook
-
Our clientele includes a mix of opioid market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa opioid market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa opioid market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
